JW Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8,379	7,511	20,222	3,920	4,923
Short-Term Investments	2,110	2,110	8,126	24,953	155.05
Cash & Short-Term Investments	10,489	9,622	28,348	28,873	5,078
Cash Growth	9.01%	-66.06%	-1.82%	468.59%	95.88%
Accounts Receivable	43,436	43,048	55,505	53,426	32,141
Other Receivables	1,344	16,784	252.42	346.01	257.79
Receivables	44,780	59,832	55,757	53,772	37,198
Inventory	31,622	35,448	23,399	22,067	21,077
Prepaid Expenses	131.29	159.78	24.78	236.47	1,044
Other Current Assets	1,266	602.96	305.56	60.7	32.79
Total Current Assets	88,289	105,664	107,834	105,008	64,430
Property, Plant & Equipment	128,653	132,051	124,577	131,555	137,145
Long-Term Investments	582.85	558.57	10,419	4,390	8,934
Goodwill	32,389	74,266	950.99	950.99	950.99
Other Intangible Assets	44,490	3,220	2,870	3,100	3,671
Long-Term Deferred Tax Assets	-	-	15.81	-	-
Long-Term Deferred Charges	192.47	248.81	305.14	484.8	689.12
Other Long-Term Assets	23,610	9,315	8,865	7,453	3,646
Total Assets	318,206	325,324	255,836	252,942	219,467
Accounts Payable	16,900	19,617	18,740	15,118	12,496
Accrued Expenses	1,540	1,669	1,271	1,156	724.7
Short-Term Debt	17,800	27,700	15,700	36,681	44,350
Current Portion of Long-Term Debt	31,137	8,112	30,353	336	336
Current Portion of Leases	296.15	350.82	44.91	131.02	159.77
Current Income Taxes Payable	2,046	8,594	2,739	3,645	3,279
Other Current Liabilities	14,707	14,136	25,411	22,976	22,557
Total Current Liabilities	84,428	80,179	94,259	80,044	83,902
Long-Term Debt	-	31,899	168	30,007	1,610
Long-Term Leases	1,339	1,176	46.68	40.42	31.91
Pension & Post-Retirement Benefits	4,050	4,001	-	-	-
Long-Term Deferred Tax Liabilities	7,728	7,406	1,828	2,011	2,243
Other Long-Term Liabilities	82.81	217.94	141.95	508.07	187.8
Total Liabilities	97,628	124,879	96,443	112,610	87,975
Common Stock	39,586	39,586	39,586	39,586	39,586
Additional Paid-In Capital	28,335	28,335	28,335	28,335	28,335
Retained Earnings	152,918	132,422	98,220	79,160	70,319
Treasury Stock	-6,749	-6,749	-6,749	-6,749	-6,749
Comprehensive Income & Other	6,487	6,850	0	0	0
Shareholders' Equity	220,578	200,445	159,393	140,332	131,492
Total Liabilities & Equity	318,206	325,324	255,836	252,942	219,467
Total Debt	50,573	69,238	46,313	67,195	46,488
Net Cash (Debt)	-40,084	-59,616	-17,965	-38,322	-41,410
Net Cash Per Share	-2588.10	-3850.39	-1160.20	-2474.87	-2657.82
Filing Date Shares Outstanding	15.5	15.48	15.48	15.48	15.48
Total Common Shares Outstanding	15.5	15.48	15.48	15.48	15.48
Working Capital	3,861	25,485	13,574	24,965	-19,472
Book Value Per Share	14233.31	12944.82	10293.69	9062.74	8491.82
Tangible Book Value	143,699	122,959	155,573	136,281	126,870
Tangible Book Value Per Share	9272.52	7940.73	10046.95	8801.12	8193.30
Land	41,313	41,313	32,459	32,459	32,459
Buildings	34,088	36,983	39,820	41,648	42,618
Machinery	50,040	49,269	51,450	56,836	44,976
Construction In Progress	1,599	2,987	758.47	440.73	16,903

Source: S&P Global Market Intelligence. Standard template. Financial Sources.